Abnova produce y desarrolla mas de 19.000 proteínas recombinantes, mas de 12.000 anticuerpos MaxPab, mas de 16.000 anticuerpos monoclonales y mas de 20.000 anticuerpos policlonales dirigidos al genoma humano.
MCAM VHH recombinant monoclonal antibody
MIF VHH recombinant monoclonal antibody
MMP9 VHH recombinant monoclonal antibody
MSLN VHH recombinant monoclonal antibody
MST1R VHH recombinant monoclonal antibody
MSTN VHH recombinant monoclonal antibody
MUC1 VHH recombinant monoclonal antibody
MUC16 VHH recombinant monoclonal antibody
NCAM1 VHH recombinant monoclonal antibody
NGFB VHH recombinant monoclonal antibody
NOTCH1 VHH recombinant monoclonal antibody
NOTCH2 VHH recombinant monoclonal antibody